Cohort (n=300,269)
Yes
In patients hospitalized for NSTE-ACS, 30-day readmissions occur in 13.4% of cases, primarily driven by heart failure and recurrent MI, with high comorbidity burden and ESRD being strong predictors of readmission.
Answers are grounded in this paper and cite their sources.
Supports risk stratification by comorbidity in NSTE-ACS; hypothesis-generating for interventions to reduce readmissions.
BACKGROUND: Despite improvements in acute care and survival after non-ST-elevation acute coronary syndrome (NSTE-ACS) hospitalization, early readmissions remain common, and have significant clinical and financial impact. OBJECTIVES: Determine the predictors and etiologies of 30-day readmissions in NSTE-ACS. METHOD: The study cohort was derived from the National Readmission Database 2014 identifying patients with a primary diagnosis of NSTE-ACS using ICD9 code. RESULTS: We identified a total of 300,269 patients admitted with NSTE-ACS; 13.4% were readmitted within 30-day. The most common cause of readmission was heart failure (HF) (15.6%), followed by a recurrent myocardial infarction (MI) (10%). Predictors of increased readmissions were age ≥ 75 years (OR: 1.34, 95% CI: 1.30-1.39), female gender (OR 1.12, 95% CI 1.09-1.16), a Charlson Comorbidity Index (CCI) >3 (OR 2.11, 95% CI: 2.04-2.18), ESRD (OR 2.01, 95% CI 1.89-2.14), CKD (OR: 1.58, 95% CI: 1.51-1.64), length of stay ≥5 days (OR: 1.51, 95% CI 1.46-1.56) and adverse events during the index admission such as AKI (OR:1.31, 95% CI: 1.25-1.36), major bleeding (OR:1.20, 95% CI: 1.12-1.24); whereas admission to a teaching hospital (OR 0.92, 95% CI 0.89-0.95) and PCI (OR 0.70, 95% CI 0.67-0.72) were associated with less likelihood of 30-day readmission. CONCLUSION: Readmission rate at 30-days is high among NSTE-ACS patients and the most common readmission etiologies are HF and recurrent MI. A CCI more than 3 and ESRD were the most significant predictors for readmission; patients undergoing PCI had less odds of readmission.
No takes yet. Share an insight, caveat, or question.
Lemor et al. (2018) conducted a cohort in non-ST-elevation acute coronary syndrome (NSTE-ACS) (n=300,269). Charlson Comorbidity Index >3 vs. Charlson Comorbidity Index ≤3 was evaluated on 30-day readmission (OR 2.11, 95% CI 2.04-2.18).
Synapse has enriched 10 related papers. Consider them for comparative context: